Purchase Order 36C24824P0208
Award Date 10/31/23
Potential Completion Date 11/30/23
Potential Value Not listed
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $645,701.90 firm-fixed-price delivery order contract to Cardinal Health 414, LLC for the radiopharmaceutical product XOFIGO. This order is part of the company's existing multi-year indefinite delivery contracts valued up to $39.8 million to provide radiopharmaceuticals and related supplies to VA medical centers and networks nationwide. Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is a major...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $15,863.85 firm-fixed-price purchase order to Cardinal Health 414, LLC for the delivery of an emergency dose of the radiopharmaceutical Xofigo. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. that specializes in providing radiopharmaceuticals and other medical products to federal agencies such as the VA, Department of Defense, and...
- This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical Xofigo, used in the treatment of prostate cancer. The contract has a potential value of $12,970.58 and a completion date of February 10, 2023. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and other...
- The Department of Veterans Affairs Veterans Health Administration awarded a $145,396.89 firm fixed price delivery order contract to Cardinal Health 414, LLC to provide the radiopharmaceutical product Xofigo. The contract has a completion date of May 31, 2019 and was awarded on July 16, 2018. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. Cardinal Health 414 has delivered a range of pharmaceutical products and services, including...
- The Department of Veterans Affairs Veterans Health Administration awarded Cardinal Health 414, LLC a $0.00 firm fixed price delivery order for XOFIGO under the Prime Vendor Pharmaceuticals contract vehicle. As the parent company, Cardinal Health, Inc. will support product distribution to the Veterans Integrated Service Network 4 location in Lebanon, Pennsylvania through June 2023. No set-aside provisions were applied to this order to supply the radioisotope product for treatment of patients...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a $392,000 firm fixed price delivery order against an unspecified government-wide acquisition contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The delivery order is for the provision of XOFIGO-Radiopharmaceutical to the agency's medical center in Dublin, Ohio, with performance required by December 30, 2020. No set-aside designation was applied to...
- This is a $12,623.78 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical product XOFIGO, used in the treatment of prostate cancer. Cardinal Health 414 is a key provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal healthcare...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical product XOFIGO, with a potential value of $150,000.00. The contract has a completion date of June 1, 2024. Cardinal Health 414 has previously held multiple indefinite delivery contracts to provide radiopharmaceuticals, specialized pharmaceuticals, and...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a firm fixed-price purchase order valued at $74,962.90 for XOFIGO (radium-223 dichloride), a specialized radiopharmaceutical used in oncology treatment. The contract was awarded on January 9, 2026, with an ultimate completion date of July 31, 2026, and carries no set-aside designation, indicating full and open competition. The award was issued by Veterans Integrated Service Network 17 (VISN 17), the civilian...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a $317,697.83 firm fixed price delivery order to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide XOFIGO. The delivery order was awarded on January 11, 2021 with a completion date of January 10, 2022. No set aside designation was used for this procurement. Cardinal Health 414, LLC will deliver the products to the place of performance in Philadelphia,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $13,833 purchase order to Cardinal Health 414, LLC Nphs Division for an emergency dose of Xofigo. As the parent company, Cardinal Health, Inc. will support delivery of the radioactive therapeutic pharmaceutical to the VA medical center in Dublin, Ohio by the end of November 2023. The firm fixed price contract utilizes no set-aside designations and does not specify any major subcontractors. This appears to be a short-term order to the VA's oncology programs for an FDA-approved radiopharmaceutical drug used to treat prostate cancer that has spread to the bones.
Generated 12/15/23, 2:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($14k) | 9/4/24 | |
| Not listed | Not listed | $13.8k | 10/31/23 |